Imatinib (INN), marketed by Novartis as Gleevec or Glivec investigational name
STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, ...
Jul 15, 2016 ... Imatinib is used to treat certain types of leukemia (cancer that begins in the white
blood cells) and other cancers of the blood cells. Imatinib is ...
This page contains brief information about imatinib mesylate and a collection of
links to more information about the use of this drug, research results, and ...
Learn about GLEEVEC® (imatinib mesylate), approved for the treatment of KIT+
GIST and Ph+ CML. See full Safety and Prescribing Information.
Imatinib is a tyrosine kinase inhibitor. Binding studies are compatible with
competitive inhibition of ATP binding [1, 4]. It inhibits the Abelson (Abl) tyrosine
Find patient medical information for imatinib oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
(eye-MAT-eh-nib mez-i-late). Trade name: Gleevec<sup>TM</sup> Other names: STI-571.
Gleevec is the trade name for the generic drug name Imatinib Mesylate. STI-571
Medscape - Leukemia dosing for Gleevec (imatinib), frequency-based adverse
effects, comprehensive interactions, contraindications, pregnancy & lactation ...
Imatinib is a tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits
the BCR-ABL kinase created by chromosome rearrangements in CHRONIC ...
Get information about a drug called imatinib (Glivec®), a targeted therapy used to
treat certain types of leukaemia and soft tissue sarcoma, and some other ...